Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.
Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.
复制标题
DOI:
10.1016/j.drugalcdep.2013.02.036
复制
发表时间:
2013-09-01
影响因子:
4.2
通讯作者:
Grant BF
中科院分区:
文献类型:
--
作者:
Compton WM;Dawson DA;Goldstein RB;Grant BF
Ascertaining agreement between DSM-IV and DSM-5 is important to determine the applicability of treatments for DSM-IV conditions to persons diagnosed according to the proposed DSM-5. Data from a nationally representative sample of US adults were used to compare concordance of past-year DSM-IV Opioid, Cannabis, Cocaine and Alcohol Dependence with past-year DSM-5 disorders at thresholds of 3+, 4+ 5+ and 6+ positive DSM-5 criteria among past-year users of opioids (n=264), cannabis (n=1,622), cocaine (n=271) and alcohol (n=23,013). Substance-specific 2×2 tables yielded overall concordance (kappa), sensitivity, specificity, positive predictive values (PPV) and negative predictive values (NPV). For DSM-IV Alcohol, Cocaine and Opioid Dependence, optimal concordance occurred when 4+ DSM-5 criteria were endorsed, corresponding to the threshold for moderate DSM-5 Alcohol, Cocaine and Opioid Use Disorders. Maximal concordance of DSM-IV Cannabis Dependence and DSM-5 Cannabis Use Disorder occurred when 6+ criteria were endorsed, corresponding to the threshold for severe DSM-5 Cannabis Use Disorder. At these optimal thresholds, sensitivity, specificity, PPV and NPV generally exceeded 85% (>75% for cannabis). Overall, excellent correspondence of DSM-IV Dependence with DSM-5 Substance Use Disorders was documented in this general population sample of alcohol, cannabis, cocaine and opioid users. Applicability of treatments tested for DSM-IV Dependence is supported by these results for those with a DSM-5 Alcohol, Cocaine or Opioid Use Disorder of at least moderate severity or Severe Cannabis Use Disorder. Further research is needed to provide evidence for applicability of treatments for persons with milder substance use disorders.
登录
查看更多内容
影响因子:
11.5
作者:
Tetrault JM;Fiellin DA
通讯作者:
Fiellin DA
影响因子:
6
作者:
Mewton, Louise;Slade, Tim;Teesson, Maree
通讯作者:
Teesson, Maree
DOI:
10.1111/j.1530-0277.2012.01930.x
发表时间:
2013-01-01
影响因子:
3.2
作者:
Dawson, Deborah A.;Goldstein, Rise B.;Grant, Bridget F.
通讯作者:
Grant, Bridget F.
影响因子:
2.2
作者:
Winhusen T;Brady KT;Stitzer M;Woody G;Lindblad R;Kropp F;Brigham G;Liu D;Sparenborg S;Sharma G;Vanveldhuisen P;Adinoff B;Somoza E
通讯作者:
Somoza E
影响因子:
3.4
作者:
Litten RZ;Egli M;Heilig M;Cui C;Fertig JB;Ryan ML;Falk DE;Moss H;Huebner R;Noronha A
通讯作者:
Noronha A